MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 149.50M | 127.63M | 165.49M | 154.05M | 149.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 149.50M | 127.63M | 165.49M | 154.05M | 149.96M |
| Cost of Revenue | 183.18M | 183.47M | 181.59M | 186.45M | 189.49M |
| Gross Profit | -33.68M | -55.85M | -16.09M | -32.40M | -39.53M |
| SG&A Expenses | 39.16M | 57.74M | 61.93M | 67.06M | 71.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 222.34M | 241.21M | 243.52M | 253.50M | 260.54M |
| Operating Income | -72.84M | -113.58M | -78.03M | -99.45M | -110.58M |
| Income Before Tax | -75.29M | -74.84M | -35.35M | -54.87M | -66.02M |
| Income Tax Expenses | -672.00K | 1.05M | 1.05M | 944.00K | 944.00K |
| Earnings from Continuing Operations | -74.62 | -75.89 | -36.40 | -55.81 | -66.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.62M | -75.89M | -36.40M | -55.81M | -66.97M |
| EBIT | -72.84M | -113.58M | -78.03M | -99.45M | -110.58M |
| EBITDA | -65.67M | -106.06M | -70.46M | -91.98M | -103.04M |
| EPS Basic | -1.18 | -1.21 | -0.57 | -0.89 | -1.07 |
| Normalized Basic EPS | -0.75 | -1.10 | -0.71 | -0.91 | -1.02 |
| EPS Diluted | -1.18 | -1.21 | -0.58 | -0.89 | -1.08 |
| Normalized Diluted EPS | -0.75 | -1.10 | -0.71 | -0.91 | -1.02 |
| Average Basic Shares Outstanding | 252.62M | 252.12M | 251.63M | 251.16M | 250.48M |
| Average Diluted Shares Outstanding | 252.67M | 252.17M | 251.75M | 251.28M | 250.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |